Babak Azad - Dec 8, 2022 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Chief Marketing Officer and SVP, Marketing & Communications
Signature
/s/ Gracye Cheng, as Attorney-in-Fact for Babak Azad, Gracye Cheng, as Attorney-in-Fact for Babak Azad
Stock symbol
GDRX
Transactions as of
Dec 8, 2022
Transactions value $
-$35,134
Form type
4
Date filed
12/12/2022, 04:19 PM
Previous filing
Sep 26, 2022
Next filing
Mar 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise +20.4K +408.02% 25.4K Dec 8, 2022 Direct F1
transaction GDRX Class A Common Stock Tax liability -$35.1K -7.06K -27.77% $4.98 18.3K Dec 8, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Options Exercise $0 -20.4K -6.25% $0.00 306K Dec 8, 2022 Class A Common Stock 20.4K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximtely equal quarterly installments thereafter for 15 quarters.

Remarks:

Chief Marketing Officer and SVP, Marketing & Communications